Akademisyen
TOLGA SÜTLÜ
DOKTOR ÖĞRETİM ÜYESİ
ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ MÜHENDİSLİK VE DOĞA BİLİMLERİ FAKÜLTESİ MOLEKÜLER BİYOLOJİ VE GENETİK BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Temel İmmünoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 29
- Proje 0
- Kitap 0
- Bildiri 14
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
16
Q2
9
Q3
2
Q4
0
WoS (JCR)
Q1
14
Q2
4
Q3
8
Q4
1
TR Index
1
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
81.8%
Üst %1 payı
0.0%
Üst %10 payı
50.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2023 TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer YÖKSİS TR Index SJR Q3 JCR Q3
- 2022 Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination. YÖKSİS SJR Q2 JCR Q3
- 2022 Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination YÖKSİS SJR Q2 JCR Q3
- 2022 Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination YÖKSİS SJR Q2 JCR Q3
- 2022 Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination YÖKSİS SJR Q2 JCR Q3
- 2022 Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination YÖKSİS SJR Q2 JCR Q3
- 2022 Human immunodeficiency virus type 1 impairs sumoylation. YÖKSİS SJR Q1 JCR Q1
- 2020 Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D. YÖKSİS
- 2019 Plasmonic Selection of ssDNA Aptamers against Fibroblast Growth Factor Receptor YÖKSİS SJR Q1 JCR Q1 OpenAlex 73.3%
- 2019 Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 90.4%
- 2019 Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS YÖKSİS SJR Q1 JCR Q1
- 2015 Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma YÖKSİS SJR Q1 JCR Q1
- 2014 Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model YÖKSİS SJR Q1 JCR Q1
- 2013 In search of the molecular consequences of 8p21 deletion in multiple myeloma: commentary on Gmidéne et al YÖKSİS SJR Q1 JCR Q3
- 2012 Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy YÖKSİS SJR Q2 JCR Q1
- 2011 Clinical impact of chromosomal aberrations in multiple myeloma YÖKSİS SJR Q1 JCR Q1
- 2011 Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study YÖKSİS SJR Q1 JCR Q1
- 2011 Ex vivo expansion of natural killer cells: a question of function YÖKSİS SJR Q2 JCR Q1
- 2010 Suicide gene therapy for graft-versus-host disease YÖKSİS
- 2010 Constitutional inv(3) in myelodysplastic syndromes YÖKSİS SJR Q2 JCR Q2